Headache News and Research

Latest Headache News and Research

The symptoms and quality of life among individuals with post-acute sequelae of SARS-CoV-2

Researchers evaluated the symptoms and quality of life among individuals with post-acute sequelae of SARS-CoV-2 or PASC.

15 Aug 2022

Poliovirus detected in New York City wastewater

Researchers in New York detected the presence of the poliovirus in wastewater samples.

14 Aug 2022

What is the epidemiology of monkeypox infections?

A new study has described the epidemiology of monkeypox infections to understand the severity and extent of recent outbreaks in non-endemic countries.

12 Aug 2022

One Medicine: A collaboration for the benefit of both humans and animals

One Medicine is described as many different things by many different people. The UK charity that drives One Medicine – Humanimal Trust – defines it as collaboration between vets, doctors and researchers so that all humans and animals benefit from equitable and sustainable medical progress, but not at the expense of an animal’s life.

12 Aug 2022

National follow-up study identifies risk factors for a prolonged COVID-19 recovery

In one of the largest follow-up studies to date, involving 25 pediatric hospitals, more than a quarter of children and adolescents hospitalized with coronavirus infection early in the pandemic still had health problems two to four months later, either persisting symptoms or activity impairment. The study, led by Boston Children's Hospital, is published August 12 in the journal Pediatrics.

12 Aug 2022

Remdesivir activates urotensin II receptor and induces cardiomyocyte dysfunction

In newly released research, scientists assessed the cardiac effects of remdesivir.

12 Aug 2022

Novel zoonotic Langya virus identified in China

Scientists discuss their discovery of the novel Langya henipavirus in eastern China.

11 Aug 2022

Large Canadian study suggests COVID-19 mRNA vaccines are safe to use in pregnancy

COVID-19 mRNA vaccines are safe to use in pregnancy and pregnant women experienced lower rates of health events post vaccination than similarly aged, non-pregnant vaccinated people, suggests a large Canadian study published in The Lancet Infectious Diseases journal.

11 Aug 2022

Post-COVID-19 symptoms may occur in one of eight SARS-CoV-2-infected individuals

In a new study, researchers analyzed the nature, incidence, and severity of 23 COVID-19-related persistent symptoms in the Netherlands.

9 Aug 2022

Fatigue and headache among the most common symptoms following COVID-19 infections

Fatigue and headache were the most common symptoms reported by individuals an average of more than four months out from having COVID-19, investigators report.

8 Aug 2022

Elevated stress during the pandemic impacted the quality of life for kids with headache disorders

Since the beginning of the COVID-19 pandemic, many pediatric patients who suffer from headaches have experienced more frequent headaches and worsening anxiety and mood, and a new study finds links to stress, decreased physical activity and increased screen time.

5 Aug 2022

Experts analyze the nature, prevalence, and severity of long-term symptoms related to COVID-19

One in eight adults (12.7%) who are infected with SARS-CoV-2 experience long term symptoms due to COVID-19, suggests a large Dutch study published in The Lancet.

5 Aug 2022

What is the viral rebound in untreated COVID-19 infections?

Researchers assessed the coronavirus disease 2019 (COVID-19) rebound in untreated COVID-19 infections.

4 Aug 2022

‘Children are not little adults’ and need special protection during heat waves

After more than a week of record-breaking temperatures across much of the country, public health experts are cautioning that children are more susceptible to heat illness than adults are — even more so when they're on the athletic field, living without air conditioning, or waiting in a parked car.

4 Aug 2022

Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

Headache News and Research

Latest Headache News and Research

The symptoms and quality of life among individuals with post-acute sequelae of SARS-CoV-2

Poliovirus detected in New York City wastewater

What is the epidemiology of monkeypox infections?

One Medicine: A collaboration for the benefit of both humans and animals

National follow-up study identifies risk factors for a prolonged COVID-19 recovery

Remdesivir activates urotensin II receptor and induces cardiomyocyte dysfunction

Novel zoonotic Langya virus identified in China

Large Canadian study suggests COVID-19 mRNA vaccines are safe to use in pregnancy

Post-COVID-19 symptoms may occur in one of eight SARS-CoV-2-infected individuals

Fatigue and headache among the most common symptoms following COVID-19 infections

Elevated stress during the pandemic impacted the quality of life for kids with headache disorders

Experts analyze the nature, prevalence, and severity of long-term symptoms related to COVID-19

What is the viral rebound in untreated COVID-19 infections?

‘Children are not little adults’ and need special protection during heat waves

Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

How can researchers profile post-COVID syndromes among distinct SARS-CoV-2 variants?

Long-term symptoms 23 months after SARS-CoV-2 infection

Symptoms of monkeypox differ from previous outbreaks

CDC study describes safety profile of second mRNA COVID booster

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Headache News and Research

Latest Headache News and Research

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in